Katherine A. Hoadley

165.8k citations

140 papers · 8.1k indexed · 4 hit papers · h-index 41

Oncology top 0.5%
Molecular Biology top 2%
Cancer Research top 0.2%
Pulmonary and Respiratory Medicine top 1%
Surgery top 2%

Co-authors: Charles M. Perou Joel S. Parker Huihui Fan Melissa A. Troester Jen Jen Yeh Lisa A. Carey Eric F. Lock Xiaping He
Topics: Cancer Genomics and Diagnostics (47 papers)Breast Cancer Treatment Studies (25 papers)HER2/EGFR in Cancer Research (17 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Nature Communications
Partner nations: United States Canada Spain

In The Last Decade

Katherine A. Hoadley

127 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

2015 1.2k citations Katherine A. Hoadley, Naim U. Rashid et al. profile →
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

2014 613 citations Jeffrey S. Damrauer, Katherine A. Hoadley et al. profile →
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays

2016 373 citations Katherine A. Hoadley, Charles M. Perou et al. profile →
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set

2016 287 citations Katherine A. Hoadley, Charles M. Perou et al. npj Breast Cancer profile →

Peers

Countries citing papers authored by Katherine A. Hoadley

Since Specialization

Citations

This map shows the geographic impact of Katherine A. Hoadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine A. Hoadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine A. Hoadley more than expected).

Fields of papers citing papers by Katherine A. Hoadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine A. Hoadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine A. Hoadley. The network helps show where Katherine A. Hoadley may publish in the future.

Co-authorship network of co-authors of Katherine A. Hoadley

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine A. Hoadley. A scholar is included among the top collaborators of Katherine A. Hoadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine A. Hoadley. Katherine A. Hoadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets 2025 ·npj Breast Cancer ·(unknown),Aranzazu Fernández-Martínez,Cheng Fan,Adam D. Pfefferle,Michele C. Hayward,Katherine A. Hoadley,Naim U. Rashid,Sara M. Tolaney,George Somlo,Lisa A. Carey,William M. Sikov,Charles M. Perou	0
2	DAB2IP loss in luminal a breast cancer leads to NF-κB–associated aggressive oncogenic phenotypes 2024 ·JCI Insight ·Angana Mukherjee,(unknown),(unknown),(unknown),Aaron Ebbs,Daniel P. Hollern,Philip M. Spanheimer,Katherine A. Hoadley,Melissa A. Troester,Jeremy M. Simon,Albert S. Baldwin	1
3	Diffsig: Associating Risk Factors with Mutational Signatures 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown),(unknown),(unknown),Andrea Walens,Di Wu,Katherine A. Hoadley,Melissa A. Troester,Michael I. Love	0
4	Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer RevealsTP53Aneuploidy–driven Metabolic Reprogramming 2023 ·Cancer Research Communications ·Marni B. McClure,Yasunori Kogure,Naser Ansari‐Pour,Yuki Saito,Hann‐Hsiang Chao,Jonathan H. Shepherd,Mariko Tabata,Olufunmilayo I. Olopade,David C. Wedge,Katherine A. Hoadley,Charles M. Perou,Keisuke Kataoka	11
5	Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study 2023 ·npj Breast Cancer ·Yifeng Shi,(unknown),Katherine A. Hoadley,Benjamin C. Calhoun,J. S. Marron,Joseph Geradts,Marc Niethammer,Melissa A. Troester	9
6	Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) 2023 ·Clinical Cancer Research ·Holly Tovey,(unknown),Joel S. Parker,Katherine A. Hoadley,Jelmar Quist,Sarah Kernaghan,Lucy Kilburn,Roberto Salgado,Sherene Loi,Richard D. Kennedy,Ioannis Roxanis,Patrycja Gazińska,Sarah E. Pinder,Judith M. Bliss,Charles M. Perou,Syed Haider,Anita Grigoriadis,Andrew Tutt,Maggie C.U. Cheang	3
7	RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Andrea Walens,(unknown),(unknown),(unknown),(unknown),Xiaohua Gao,Alina M. Hamilton,Erin L. Kirk,Michael I. Love,Gaorav P. Gupta,Charles M. Perou,Cyrus Vaziri,Katherine A. Hoadley,Melissa A. Troester	9
8	Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer 2022 ·Nature Communications ·Jeffrey S. Damrauer,(unknown),Jeffrey A. Klomp,Mi Zhou,Elizabeth R. Plimack,Matthew D. Galsky,Petros Grivas,Noah M. Hahn,Peter H. O’Donnell,Gopa Iyer,David I. Quinn,Benjamin G. Vincent,Diane Zipursky Quale,Sara E. Wobker,Katherine A. Hoadley,William Y. Kim,Matthew I. Milowsky	27
9	Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population 2022 ·Cancer Research Communications ·Alina M. Hamilton,(unknown),Xiaohua Gao,(unknown),Benjamin C. Calhoun,Michael I. Love,Melissa A. Troester,Katherine A. Hoadley	4
10	Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases 2022 ·npj Breast Cancer ·Amber N. Hurson,Mustapha Abubakar,Alina M. Hamilton,Kathleen Conway,Katherine A. Hoadley,Michael I. Love,Andrew F. Olshan,Charles M. Perou,Montserrat García‐Closas,Melissa A. Troester	3
11	Genomic characterization of rare molecular subclasses of hepatocellular carcinoma 2021 ·Communications Biology ·Jeffrey S. Damrauer,(unknown),Vonn Walter,Aatish Thennavan,Lisle E. Mose,Sara R. Selitsky,Katherine A. Hoadley	5
12	SCISSOR: a framework for identifying structural changes in RNA transcripts 2021 ·Nature Communications ·(unknown),Heejoon Jo,Xiaobei Zhao,Katherine A. Hoadley,Scott Newman,(unknown),Michele C. Hayward,Michael I. Love,J. S. Marron,D. Neil Hayes	6
13	Molecular analysis of TCGA breast cancer histologic types 2021 ·Cell Genomics ·Aatish Thennavan,Francisco Beça,(unknown),Susana García‐Recio,Kimberly H. Allison,Laura C. Collins,Gary M. Tse,Yunn‐Yi Chen,Stuart J. Schnitt,Katherine A. Hoadley,Andrew H. Beck,Charles M. Perou	62
14	An approach for normalization and quality control for NanoString RNA expression data 2020 ·Briefings in Bioinformatics ·Arjun Bhattacharya,Alina M. Hamilton,Helena Furberg,Eugene J. Pietzak,Mark P. Purdue,Melissa A. Troester,Katherine A. Hoadley,Michael I. Love	70
15	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators 2020 ·PLoS Biology ·(unknown),(unknown),Xianxi Wang,Rochelle L. Tiedemann,Thomas Bonacci,Rajarshi Choudhury,(unknown),(unknown),(unknown),Jeffrey S. Damrauer,Feng Yan,Joseph S. Harrison,Michael B. Major,Katherine A. Hoadley,Aussie Suzuki,Scott B. Rothbart,Nicholas G. Brown,Michael J. Emanuele	9
16	Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis 2016 ·Molecular Cancer Research ·(unknown),Katherine A. Hoadley,(unknown),Dereje D. Jima,Michael S. Bereman,(unknown),(unknown),David A. McDonald,Melissa A. Troester,Charles M. Perou,Jodie M. Fleming	21
17	Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer 2014 ·Clinical Cancer Research ·Michael D. Iglesia,Benjamin G. Vincent,Joel S. Parker,Katherine A. Hoadley,Lisa A. Carey,Charles M. Perou,Jonathan S. Serody	194
18	Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer 2012 ·Clinical Cancer Research ·Heather Ann Brauer,Liza Makowski,Katherine A. Hoadley,Patricia Casbas-Hernández,(unknown),Erick Romàn-Pèrez,Monica D’Arcy,Alex J. Freemerman,Charles M. Perou,Melissa A. Troester	78
19	Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types 2010 ·Clinical Cancer Research ·Matthew D. Wilkerson,Xiaoying Yin,Katherine A. Hoadley,Yufeng Liu,Michele C. Hayward,Christopher R. Cabanski,Kenneth L. Muldrew,C. Ryan Miller,Scott H. Randell,Mark A. Socinski,Alden M. Parsons,William K. Funkhouser,Carrie B. Lee,Patrick J. Roberts,Leigh B. Thorne,Philip S. Bernard,Charles M. Perou,D. Neil Hayes	194
20	Cell-Type-Specific Responses to Chemotherapeutics in Breast Cancer 2004 ·Cancer Research ·Melissa A. Troester,Katherine A. Hoadley,Thérese Sørlie,Brittney‐Shea Herbert,Anne‐Lise Børresen‐Dale,Per Eystein Lønning,Jerry W. Shay,William K. Kaufmann,Charles M. Perou	143

About Katherine A. Hoadley

Katherine A. Hoadley is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 140 papers that have together received 8.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (47 papers), Breast Cancer Treatment Studies (25 papers) and HER2/EGFR in Cancer Research (17 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (3.8k citations) and Molecular Biology (3.5k citations). Katherine A. Hoadley has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Charles M. Perou, Joel S. Parker, Huihui Fan, Melissa A. Troester, Jen Jen Yeh, Lisa A. Carey, Eric F. Lock, Xiaping He, J. S. Marron and Andrew B. Nobel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact